![Stephen Rubino](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Rubino
Directeur Général chez
Sporos Bioventures, Inc.
Profil
Stephen Rubino is currently the President, Chief Executive Officer & Director at Sporos Bioventures LLC and a Director at Sermonix Pharmaceuticals LLC.
He previously served as a Director at ILKOS THERAPEUTICS, Inc. from 2017 to 2020, an Independent Director at Viracta Therapeutics, Inc. from 2021 to 2024, the Head-Global Solid Tumor at Schering-Plough Europe SA from 1991 to 2001, and the Global Head-Business Development at Novartis Pharmaceuticals Corp.
from 2001 to 2017.
He also held the position of Chief Business Officer at Celyad Oncology SA from 2020 to 2022 and Chief Business & Strategy Officer at Omega Therapeutics, Inc. from 2018 to 2019.
Dr. Rubino holds an MBA from Baruch College and a doctorate from Weill Cornell Medical College.
Postes actifs de Stephen Rubino
| Sociétés | Poste | Début |
|---|---|---|
Sermonix Pharmaceuticals LLC
 Sermonix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
Sporos Bioventures, Inc.
 Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Directeur Général | - |
Anciens postes connus de Stephen Rubino
| Sociétés | Poste | Fin |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 31/10/2024 |
| CELYAD ONCOLOGY SA | Corporate Officer/Principal | 01/04/2022 |
ILKOS THERAPEUTICS, Inc.
 ILKOS THERAPEUTICS, Inc. BiotechnologyHealth Technology Operates biotechnology company | Directeur/Membre du Conseil | 01/02/2020 |
| OMEA THER | Corporate Officer/Principal | 01/05/2019 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | 01/01/2017 |
Formation de Stephen Rubino
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
80
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Schering-Plough Europe SA | |
Baruch College
 Baruch College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Celyad Oncology SA
 Celyad Oncology SA BiotechnologyHealth Technology Develops immuno-oncology and cardiology products | Health Technology |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sermonix Pharmaceuticals LLC
Sermonix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
ILKOS THERAPEUTICS, Inc.
ILKOS THERAPEUTICS, Inc. BiotechnologyHealth Technology Operates biotechnology company | Health Technology |
Omega Therapeutics, Inc.
 Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
Sporos Bioventures, Inc.
Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Viracta Therapeutics, Inc.
 Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers | Health Technology |
